Parkes,David G

Institution: Amylin Pharmaceuticals, San Diego, CA, USA

Top Collaborators: Smith PA, Roth JD, Tatarkiewicz K, Jodka CM, Deyoung MB, Lowe C, Lwin A, Villescaz C, Hargrove DM, Gedulin BR, Lu MG, Mack CM, Janssen S, Wilson JK, Athanacio JR, Liu Q, Polizzi C, Turek VF, Adams L, Trevaskis JL

Research Interests: Rats, Amylin, Glp-1, Glucagon, Treatment, Cell, Hormone, Obesity, Glucagon-like Peptide-1, Insulin, Glucose, Rodents, Future, Insulin Sensitivity, Sensitivity, Caerulein, Concentrations, Mice, Patients, Risk